home / stock / mygn / mygn quote
Last: | $21.56 |
---|---|
Change Percent: | 0.75% |
Open: | $21.35 |
Close: | $21.40 |
High: | $21.67 |
Low: | $21.16 |
Volume: | 154,486 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$21.56 | $21.35 | $21.4 | $21.67 | $21.16 | 154,486 | 03-28-2024 |
$21.4 | $21.8 | $21.4 | $21.8 | $21.33 | 505,033 | 03-27-2024 |
$21.49 | $22.12 | $21.49 | $22.2699 | $21.47 | 548,799 | 03-26-2024 |
$21.98 | $22.04 | $21.98 | $22.25 | $21.57 | 555,671 | 03-25-2024 |
$22.24 | $22.33 | $22.24 | $22.485 | $21.883 | 417,711 | 03-22-2024 |
$22.3 | $22.4 | $22.3 | $22.72 | $21.93 | 820,411 | 03-21-2024 |
$22.24 | $21.55 | $22.24 | $22.265 | $21.18 | 711,282 | 03-20-2024 |
$21.6 | $21.72 | $21.6 | $21.925 | $21.44 | 413,997 | 03-19-2024 |
$21.63 | $21.07 | $21.63 | $21.71 | $20.8926 | 620,560 | 03-18-2024 |
$21.16 | $21.17 | $21.16 | $21.7 | $21.04 | 2,270,198 | 03-15-2024 |
$21.32 | $21.25 | $21.32 | $21.59 | $20.99 | 872,236 | 03-14-2024 |
$21.53 | $21.71 | $21.53 | $22.18 | $21.3 | 456,571 | 03-13-2024 |
$21.57 | $22.38 | $21.57 | $22.59 | $20.58 | 496,301 | 03-12-2024 |
$22.58 | $22.61 | $22.58 | $23.29 | $22.46 | 499,560 | 03-11-2024 |
$22.61 | $23.01 | $22.61 | $23.46 | $22.46 | 348,133 | 03-08-2024 |
$22.81 | $23.15 | $22.81 | $23.37 | $22.44 | 718,355 | 03-07-2024 |
$22.94 | $22.61 | $22.94 | $23.7299 | $22.39 | 835,653 | 03-06-2024 |
$22.23 | $21.76 | $22.23 | $22.31 | $21.515 | 576,222 | 03-05-2024 |
$21.97 | $22.21 | $21.97 | $22.21 | $21.15 | 554,602 | 03-04-2024 |
$22.18 | $21.03 | $22.18 | $22.21 | $20.59 | 867,950 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
SALT LAKE CITY, March 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, tod...
SALT LAKE CITY, March 21, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced that the United States Patent and Trademark Office has issued a patent that will strengthen its ability to deliver a tumor-informe...
SALT LAKE CITY, March 20, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ:MYGN), a leader in genetic testing and precision medicine, tod...